Roche Diagnostics India launches Mobile App REACH To Alleviate the Emotional and Mental Health Burden of Healthcare Workers Kumar Jeetendra | June 29, 2021 Mumbai: 29 June 2021: Roche Diagnostics India launches REACH, a wellness platform developed to support the emotional well-being of healthcare professionals. As the world is battling the COVID-19 pandemic, frontline healthcare workers (HCWs) are among the most vulnerable groups at risk of mental health problems. REACH aims to be a trustworthy companion for frontline workers …
The Launch of U-Load Dextramer® with Peptide Receptive MHC I and MHC II Monomers Greatly Expands Flexibility while Ensuring Reliable Sensitivity in Exploring Diversity of Cellular Immune Responses Kumar Jeetendra | June 25, 2021 Virum, Denmark – 24 June 2021 – Life Science Newswire – Immudex announces the launch of the new U-Load Dextramer® product line that allows scientists to swiftly assemble their own sensitive antigen-specific Dextramer® reagents for immune monitoring directly in the lab using loadable MHC class I easYmer® and the novel loadable MHC class II monomers, …
Dolomite Bio’s distributor list expands globally Kumar Jeetendra | June 23, 2021 Royston, UK – 23 June, 2021 – Dolomite Bio are pleased to announce the expansion of their current list of distributors. This exciting new chapter will enable customers in more countries than ever to easily gain access to the endless possibilities of the Nadia platform. Dolomite Bio’s CEO, Mark Gilligan, said: “After the challenges 2020 …
Celemics Partner with Strand Life Science and their StrandOmics Analysis Platform Kumar Jeetendra | June 23, 2021 June 16, 2021, Seoul Korea – Celemics co-founder and CEO Dr. Hyoki Kim announced a partnership with Strand Life Sciences, a leading precision medicine informatics company, to develop a bioinformatics solution capable of providing users with an accelerated means of producing high-quality, in-class clinical genomics reports and enabling a complete sample-to-answer solution, including assay-specific variant …
108Labs is building the world’s first cell cultured human milk factory in Hillsborough, NC Kumar Jeetendra | June 22, 2021 Hillsborough, NC – June 21, 2021 – Life Science Newswire – Eighteen months after creating the world’s first cell cultured human milk, 108Labs is now focused on accelerating the field from lab to factory by building and programming the world’s first autonomous Cellufacturing® facility and artificial intelligence platform for production of cell cultured human milk …
Celemics Partner with Strand Life Science and their StrandOmics Analysis Platform Kumar Jeetendra | June 16, 2021 June 16, 2021, Seoul Korea – Celemics(www.celemics.com) co-founder and CEO Dr. Hyoki Kim announced a partnership with Strand Life Sciences, a leading precision medicine informatics company, to develop a bioinformatics solution capable of providing users with an accelerated means of producing high-quality, in-class clinical genomics reports and enabling a complete sample-to-answer solution, including assay-specific variant …
Sygnature Discovery expands into early CMC development Kumar Jeetendra | June 16, 2021 NOTTINGHAM, UK – 16 June, 2021 –– Leading Drug Discovery Contract Research Organisation Sygnature Discovery has announced the set-up of a state-of-the-art Early Candidate Developability Screening Group. Located at its headquarters in Nottingham, UK, the new service line will expand on the company’s offerings to customers by bridging into formal preclinical drug development and paving …
Thermo Fisher Scientific Expands SARS-CoV-2 Testing Portfolio in India with Point-of-Care Testing Platform Kumar Jeetendra | June 16, 2021 Mumbai, India, June 15, 2021–Thermo Fisher Scientific today announced a introduction of the new and innovative SARS-CoV-2 Test that delivers gold-standard reverse transcription polymerase chain reaction (RT-PCR) detection of SARS-CoV-2 in a point-of-care format. The Accula SARS-CoV-2 Test has received Emergency Use Authorization (EUA) from the United States (U.S.) Food and Drug Administration (FDA) for …
Singapore-UK Team To Develop a Novel Device to Reduce Chemotherapy Side-Effects Kumar Jeetendra | June 11, 2021 Singapore – 10 June 2021 – A team of clinicians and scientists from the National University Cancer Institute, Singapore (NCIS) at the National University Hospital (NUH) and the N.1 Institute for Health at the National University of Singapore (NUS) has partnered Paxman Coolers Ltd (UK) (Paxman) to develop a device that may prevent or reduce …
HiMedia introduces Mucormycosis detection kit, MUCOdiagno to isolate fungi from Mucormycosis patients Kumar Jeetendra | June 11, 2021 HiMedia Laboratories, a bioscience company with expertise in media manufacturing and diagnostics, has developed the Mucormycosis detection kit for mucormycosis patients. The kit has been introduced under the brand name MUCO-diagnoTM [K144], which is a complete kit for clinicians to collect the sample and isolate the fungi responsible for Mucormycosis from patient’s sample. Commenting on …
ENPICOM to integrate renowned structural antibody prediction tools developed at the University of Oxford Kumar Jeetendra | June 10, 2021 The Netherlands – June 10, 2021 – ENPICOM, an innovative bioinformatics software engineering company, announced the upcoming expansion of the IGX Platform’s capabilities towards advanced liability prediction. At the Antibody Engineering and Therapeutics virtual conference, the company revealed its plans to integrate the Structural Antibody Prediction Platform (SAbPred) developed by researchers at the University of …
3Brain AG CorePlate™ technology combines microchips and AI in a revolutionary new approach to drug discovery Kumar Jeetendra | June 8, 2021 Wädenswil, Greater Zurich Area, Switzerland, June 8, 2021 – – 3Brain AG has announced a new technology based on a unique combination of microchips and AI that promises to change the way drug candidates are selected at the preclinical level to enter into clinical trials – and to maximize their chances of success. Using CorePlate™ …
